Edition:
United States

Uniqure NV (QURE.OQ)

QURE.OQ on NASDAQ Stock Exchange Global Select Market

37.46USD
15 Feb 2019
Change (% chg)

$1.49 (+4.14%)
Prev Close
$35.97
Open
$36.14
Day's High
$37.56
Day's Low
$35.31
Volume
90,516
Avg. Vol
117,310
52-wk High
$43.23
52-wk Low
$20.29

Select another date:

Fri, Feb 8 2019

UniQure gene therapy shows promising result in mid-stage trial

Gene therapy company UniQure NV said on Friday its treatment for hemophilia B increased the levels of a protein that helps in blood clotting after 12 weeks in a relatively small study.

UPDATE 2-UniQure gene therapy shows promising result in mid-stage trial

Feb 8 Gene therapy company UniQure NV said on Friday its treatment for hemophilia B increased the levels of a protein that helps in blood clotting after 12 weeks in a relatively small study.

UniQure gene therapy shows rise in blood-clotting protein in trial

Feb 8 UniQure NV said on Friday its gene therapy to treat patients with a blood disorder, hemophilia B, increased the levels of a protein that helps in blood clotting after 12 weeks.

Select another date: